Status:
COMPLETED
DLBCL Treatment in Children and Adolescents
Lead Sponsor:
Sun Yat-sen University
Conditions:
Diffuse Large B-cell Lymphoma
Eligibility:
All Genders
Up to 18 years
Brief Summary
We compared the efficacy and safety of modified NHL-BFM-90 regimen and R-CHOP/CHOP regimen in pediatric (aged 0-14 years) and adolescent（aged 15-18 years）DLBCL patients in a single institution during ...
Detailed Description
Diffuse large B-cell lymphoma (DLBCL) is an aggressive lymphoma that accounts for approximately 10%-20% of pediatric and adolescent non-Hodgkin's lymphomas (NHLs). The incidence increases with age, w...
Eligibility Criteria
Inclusion
- patients who were pathologically diagnosed with DLBCL
- patients under 18 years of age.
Exclusion
- Was administered prior chemotherapy;
- Patients who could not receive chemotherapy due to severe immunodeficiency or other diseases.
- Patients with primary central nervous system lymphomas.
Key Trial Info
Start Date :
January 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2020
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT04726995
Start Date
January 1 2000
End Date
October 1 2020
Last Update
January 27 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.